Effect of propofol-ketamin and propofol-fentanyl in colonoscopy
Phase 2
- Conditions
- disease of intestine,unspecified.disease of intestine,unspecifiedk63.9
- Registration Number
- IRCT20190529043750N1
- Lead Sponsor
- Babol University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
patients scheduled for comlete elective colonoscopy
18-55 years old
ASA class I-II
Exclusion Criteria
History of large bowel surgery
Pregnancy
Patients with psychiatric and emotional disorder
History of addiction
History of allergic reaction
History of pulmonary and metabolic disorders
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain. Timepoint: Before of discharge. Method of measurement: Visual Analogues Scale.
- Secondary Outcome Measures
Name Time Method Drug adverse effects. Timepoint: Before and after colonoscopy. Method of measurement: Before and after colonoscopy.;Colonoscopist satisfaction. Timepoint: After colonoscopy. Method of measurement: Numerical rating scale for colonoscopist satisfaction.;Blood pressure. Timepoint: Every 5 minutes. Method of measurement: Noninvasive cuff measurrment.;Heart rate. Timepoint: Every 5 minutes. Method of measurement: Pulse counting.